Opko Health Inc

Financials

Cash from operating activities 45.71 M44.41 M34.55 M83.42 M34.65 M25.92 M 178.54 M Cash from investing activities 224.67 M115.99 M40.53 M-2.83 M194.65 M-2.05 M 230.3 M Cash from financing activities 206.14 M-40.47 M4.02 M79.49 M16.21 M18.34 M 118.06 M Free cash flow 37.77 M39 M31.36 M80.14 M31.51 M23.25 M 166.26 M

OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

OPK

Financials

Opko Health Inc

ニュース

OPK Q4 Earnings & Revenues Beat Estimates, Gross Margin Contracts

OPKO Health, Inc. (OPK) Q4 2025 Earnings Call Transcript

Le BPA de Opko Health a dépassé les attentes de 0,03$, le CA a surpassé les prévisions

Opko Health earnings beat by $0.03, revenue topped estimates

Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026?

H.C. Wainwright réitère sa recommandation d’achat sur l’action Opko Health

Opko Health stock rating reiterated at Buy by H.C. Wainwright

OPKO et Entera élargissent leur collaboration pour développer un traitement oral de PTH

OPKO Health: Deeply Mispriced Ahead Of Major Catalysts (NASDAQ:OPK)

OPKO Health, Inc. (OPK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

OrthoPediatrics (KIDS) Moves 9.8% Higher: Will This Strength Last?

OPKO Health Bets on RAYALDEE and Pipeline Progress for 2026 Growth